Ozanimod

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 385 publications

PANCCO Clinical Practice Guideline Update for the treatment of ulcerative colitis in adults

PANCCO Clinical Practice Guideline Update for the treatment of ulcerative colitis in adults

Journal: Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru

Published: July 25, 2026

Novel Agents on the Therapeutic Horizon For Paediatric Inflammatory Bowel Diseases: An Analysis of Clinical Trials Registries.

Novel Agents on the Therapeutic Horizon For Paediatric Inflammatory Bowel Diseases: An Analysis of Clinical Trials Registries.

Journal: Paediatric drugs

Published: May 26, 2026

Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

Journal: Journal of Crohn's & colitis

Published: May 20, 2026

Small Molecules as Advanced Therapy for the Treatment of Inflammatory Bowel Disease, Particularly Regarding Ulcerative Colitis.

Small Molecules as Advanced Therapy for the Treatment of Inflammatory Bowel Disease, Particularly Regarding Ulcerative Colitis.

Journal: Internal medicine (Tokyo, Japan)

Published: May 17, 2026

Cardiac arrhythmias associated with S1PRMs: a pharmacovigilance study based on real-world data.

Cardiac arrhythmias associated with S1PRMs: a pharmacovigilance study based on real-world data.

Journal: Frontiers in pharmacology

Published: May 15, 2026

Nitrogen dioxide exposure promotes CD8+T cell infiltration and contributes to increased susceptibility to ulcerative colitis: An integrative multi‑omics, artificial intelligence, and mouse model study.

Nitrogen dioxide exposure promotes CD8+T cell infiltration and contributes to increased susceptibility to ulcerative colitis: An integrative multi‑omics, artificial intelligence, and mouse model study.

Journal: Journal of hazardous materials

Published: May 13, 2026

The Role of Sphingosine-1-Phosphate Signaling in Cerebral Ischemia/Reperfusion Injury and Alzheimer's Disease Pathology.

The Role of Sphingosine-1-Phosphate Signaling in Cerebral Ischemia/Reperfusion Injury and Alzheimer's Disease Pathology.

Journal: International journal of molecular sciences

Published: April 30, 2026

Therapeutic drug monitoring with non-anti-TNF advanced therapies in inflammatory bowel disease: current and evolving paradigms.

Therapeutic drug monitoring with non-anti-TNF advanced therapies in inflammatory bowel disease: current and evolving paradigms.

Journal: Frontiers in gastroenterology (Lausanne, Switzerland)

Published: April 20, 2026

Rational Design, Synthesis, and Biological Evaluation of Potent, Highly Selective 1,2,4-Oxadiazole-Based S1PR1 Agonists for UC Treatment.

Rational Design, Synthesis, and Biological Evaluation of Potent, Highly Selective 1,2,4-Oxadiazole-Based S1PR1 Agonists for UC Treatment.

Journal: Journal of medicinal chemistry

Published: April 17, 2026

Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.

Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.

Journal: International journal of molecular sciences

Published: April 15, 2026

Tacrolimus Bridging and Combination Therapy Following Infliximab and JAK Inhibitor Failure in Ulcerative Colitis: A Case Series.

Tacrolimus Bridging and Combination Therapy Following Infliximab and JAK Inhibitor Failure in Ulcerative Colitis: A Case Series.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: April 08, 2026

Influence of Ageing on the Pharmacology, Efficacy and Safety of Oral Targeted Therapies for Inflammatory Bowel Disease: Focus on Janus Kinase (JAK) Inhibitors and Sphingosine-1-Phosphate (S1P) Receptor Modulators.

Influence of Ageing on the Pharmacology, Efficacy and Safety of Oral Targeted Therapies for Inflammatory Bowel Disease: Focus on Janus Kinase (JAK) Inhibitors and Sphingosine-1-Phosphate (S1P) Receptor Modulators.

Journal: Drugs & aging

Published: April 07, 2026

Showing 1-12 of 385

Last Updated: 09/26/2026